Our News Bureau – Mumbai
Quintiles has been named best clinical research organisation (CRO) in the Vaccine Industry Excellence (ViE) Awards 2012. Presented at the World Vaccine Congress in Washington, DC, the awards recognise and celebrate the leaders, innovators and pioneers in the vaccines industry.
“This is a great honour to be recognised as the Best CRO at the World Vaccine Congress. It is a huge achievement and underscores our commitment to the development of quality vaccines and anti-infective products,” said Dr Ellen Vigdorth, VP Allergy, Respiratory, Infectious Diseases and Vaccines.
Customers voted for their preferred CRO prior to the World Vaccine Congress; a judging panel then made its selection based on the following criteria: Range of services provided in niche and core therapeutic areas; Methods of performance improvement or introduction of new services; Attention to and quality of relationships with clients; Reaching of milestones and final/ongoing outcomes; and building and maintaining existing and long-term partnerships.
Dr Vigdorth also gave a presentation on ‘Climate change in vaccine trials: Moving from a one-size-fits-all to a custom fit in operational delivery.’ In the discussion, Dr Vigdorth explored the critical role of epidemiology, temporal requirements and local customs integration into design, planning and delivery for successful vaccine trials. The presentation delved into the possible challenges and how to overcome them in a global environment through the discussion of four vaccine case studies—H1N1 influenza, pneumococcal disease, neglected diseases and malaria.
- Advertisement -
